These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Absence of "original antigenic sin" in autoimmunity provides an unforeseen platform for immune therapy. Steinman L J Exp Med; 1999 Apr; 189(7):1021-4. PubMed ID: 10190892 [No Abstract] [Full Text] [Related]
24. Molecular mimicry between a viral peptide and a myelin oligodendrocyte glycoprotein peptide induces autoimmune demyelinating disease in mice. Mokhtarian F; Zhang Z; Shi Y; Gonzales E; Sobel RA J Neuroimmunol; 1999 Mar; 95(1-2):43-54. PubMed ID: 10229114 [TBL] [Abstract][Full Text] [Related]
25. Multiple pathways to induction of virus-induced autoimmune demyelination: lessons from Theiler's virus infection. Miller SD; Olson JK; Croxford JL J Autoimmun; 2001 May; 16(3):219-27. PubMed ID: 11334486 [TBL] [Abstract][Full Text] [Related]
26. The myelin-associated oligodendrocytic basic protein region MOBP15-36 encompasses the immunodominant major encephalitogenic epitope(s) for SJL/J mice and predicted epitope(s) for multiple sclerosis-associated HLA-DRB1*1501. de Rosbo NK; Kaye JF; Eisenstein M; Mendel I; Hoeftberger R; Lassmann H; Milo R; Ben-Nun A J Immunol; 2004 Jul; 173(2):1426-35. PubMed ID: 15240739 [TBL] [Abstract][Full Text] [Related]
28. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. I. Cross-specificity among TMEV substrains and related picornaviruses, but not myelin proteins. Miller SD; Clatch RJ; Pevear DC; Trotter JL; Lipton HL J Immunol; 1987 Jun; 138(11):3776-84. PubMed ID: 2438327 [TBL] [Abstract][Full Text] [Related]
29. Autoimmune pathogenesis of multiple sclerosis: role of autoreactive T lymphocytes and new immunotherapeutic strategies. Stinissen P; Raus J; Zhang J Crit Rev Immunol; 1997; 17(1):33-75. PubMed ID: 9034723 [TBL] [Abstract][Full Text] [Related]
30. Epitope spreading and molecular mimicry as triggers of autoimmunity in the Theiler's virus-induced demyelinating disease model of multiple sclerosis. Croxford JL; Olson JK; Miller SD Autoimmun Rev; 2002 Oct; 1(5):251-60. PubMed ID: 12848977 [TBL] [Abstract][Full Text] [Related]
31. Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: preliminary analysis of MOG T cell epitopes. Kerlero de Rosbo N; Mendel I; Ben-Nun A Eur J Immunol; 1995 Apr; 25(4):985-93. PubMed ID: 7737302 [TBL] [Abstract][Full Text] [Related]
32. Myelin protein expression in lymphoid tissues: implications for peripheral tolerance. Voskuhl RR Immunol Rev; 1998 Aug; 164():81-92. PubMed ID: 9795766 [TBL] [Abstract][Full Text] [Related]
33. A virus-induced molecular mimicry model of multiple sclerosis. Olson JK; Ercolini AM; Miller SD Curr Top Microbiol Immunol; 2005; 296():39-53. PubMed ID: 16323419 [TBL] [Abstract][Full Text] [Related]
34. T cell repertoire diversity is required for relapses in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis. Fazilleau N; Delarasse C; Motta I; Fillatreau S; Gougeon ML; Kourilsky P; Pham-Dinh D; Kanellopoulos JM J Immunol; 2007 Apr; 178(8):4865-75. PubMed ID: 17404267 [TBL] [Abstract][Full Text] [Related]
35. A suppressive oligodeoxynucleotide enhances the efficacy of myelin cocktail/IL-4-tolerizing DNA vaccination and treats autoimmune disease. Ho PP; Fontoura P; Platten M; Sobel RA; DeVoss JJ; Lee LY; Kidd BA; Tomooka BH; Capers J; Agrawal A; Gupta R; Zernik J; Yee MK; Lee BJ; Garren H; Robinson WH; Steinman L J Immunol; 2005 Nov; 175(9):6226-34. PubMed ID: 16237121 [TBL] [Abstract][Full Text] [Related]